These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6309892)

  • 21. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of cytomegalovirus and Epstein-Barr virus antibody responses in treated hemophiliacs. Implications for the study of acquired immune deficiency syndrome.
    Cheeseman SH; Sullivan JL; Brettler DB; Levine PH
    JAMA; 1984 Jul; 252(1):83-5. PubMed ID: 6328057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epstein-Barr virus. Its participation in lymphoproliferative and anaplastic processes].
    Fejes M; Bachmann AE; Mochanko K
    Medicina (B Aires); 1978; 38(6 Pt 1):700-16. PubMed ID: 220495
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.
    Swaminathan S
    Semin Hematol; 2003 Apr; 40(2):107-15. PubMed ID: 12704587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus infections in males with the X-linked lymphoproliferative syndrome.
    Grierson H; Purtilo DT
    Ann Intern Med; 1987 Apr; 106(4):538-45. PubMed ID: 3030174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viral participation in cellular and microenvironmental transformation and amplification towards malignancy in AIDS patients.
    Agius LM
    Med Hypotheses; 2004; 62(4):593-9. PubMed ID: 15050113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epstein-Barr-virus-induced lymphoproliferative diseases].
    Schuster V; Kreth HW
    Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-transplant lymphoproliferative disorders: implications for acquired immunodeficiency syndrome-associated malignancies.
    Swinnen LJ
    J Natl Cancer Inst Monogr; 2001; (28):38-43. PubMed ID: 11158205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression.
    Ponticelli C
    Nephrol Dial Transplant; 2011 Jun; 26(6):1769-75. PubMed ID: 21482636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epstein-Barr virus infection and lymphoproliferative disorders in patients after renal transplantation].
    Merlino C; Giacchino F; Tognarelli G; Cavallo R; Re D; Sinesi F; Segoloni G; Negro Ponzi A
    Minerva Urol Nefrol; 1996 Sep; 48(3):139-43. PubMed ID: 8966650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous occurrence of Pneumocystis carinii pneumonia, cytomegalovirus infection, Kaposi's sarcoma, and B-immunoblastic sarcoma in a homosexual man.
    Burkes RL; Gal AA; Stewart ML; Gill PS; Abo W; Levine AM
    JAMA; 1985 Jun; 253(23):3425-8. PubMed ID: 2987560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cytomegalovirus in Kaposi's sarcoma.
    Giraldo G; Beth E; Kyalwazi SK
    IARC Sci Publ; 1984; (63):583-606. PubMed ID: 6100282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired immunodeficiency syndrome and Epstein-Barr virus.
    Lau RK
    Int J STD AIDS; 1990 Sep; 1(5):318-20. PubMed ID: 1965885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.
    Purtilo DT; Okano M; Grierson HL
    Environ Health Perspect; 1990 Aug; 88():225-30. PubMed ID: 2176975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Speculations on the viral etiology of acquired immune deficiency syndrome and Kaposi's sarcoma.
    Conant MA
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):57s-62s. PubMed ID: 6330223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is murine gammaherpesvirus-68 (MHV-68) a suitable immunotoxicological model for examining immunomodulatory drug-associated viral recrudescence?
    Aligo J; Walker M; Bugelski P; Weinstock D
    J Immunotoxicol; 2015; 12(1):1-15. PubMed ID: 24512328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodeficiency as a factor in lymphomagenesis.
    Purtilo DT; Sakamoto K
    Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency.
    Cohen JI
    Medicine (Baltimore); 1991 Mar; 70(2):137-60. PubMed ID: 1848644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Epstein-Barr virus in acquired immune deficiency syndrome.
    Purtilo DT; Kipscomb H; Krueger G; Sonnabend J; Casareale D; Volsky DJ
    Adv Exp Med Biol; 1985; 187():53-65. PubMed ID: 2994420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.